Cargando…
Novel approaches in search for biomarkers of cholangiocarcinoma
Cholangiocarcinoma (CCA) arises from the ductular epithelium of the biliary tree, either within the liver (intrahepatic CCA) or more commonly from the extrahepatic bile ducts (extrahepatic CCA). This disease has a poor prognosis and a growing worldwide prevalence. The poor outcomes of CCA are partia...
Autores principales: | Mocan, Lavinia-Patricia, Ilieș, Maria, Melincovici, Carmen Stanca, Spârchez, Mihaela, Crăciun, Rareș, Nenu, Iuliana, Horhat, Adelina, Tefas, Cristian, Spârchez, Zeno, Iuga, Cristina Adela, Mocan, Tudor, Mihu, Carmen Mihaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048460/ https://www.ncbi.nlm.nih.gov/pubmed/35582128 http://dx.doi.org/10.3748/wjg.v28.i15.1508 |
Ejemplares similares
-
Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?
por: Mocan, Tudor, et al.
Publicado: (2021) -
Refining Liver Biopsy in Hepatocellular Carcinoma: An In-Depth Exploration of Shifting Diagnostic and Therapeutic Applications
por: Spârchez, Zeno, et al.
Publicado: (2023) -
The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value
por: Mocan, Lavinia Patricia, et al.
Publicado: (2023) -
Ultrasound or Sectional Imaging Techniques as Screening Tools for Hepatocellular Carcinoma: Fall Forward or Move Forward?
por: Sparchez, Zeno, et al.
Publicado: (2021) -
Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
por: Sparchez, Zeno, et al.
Publicado: (2021)